Science Intelligence and InfoPros

Little things about Scientitic Watch and Information Professionnals

Posts Tagged ‘Bayer

Bayer apologizes for uncontrolled tweets

leave a comment »

Bayer (BAYRY)’s apology for two tweets about the erectile dysfunction drug Levitra and multiple sclerosis therapy Sativex shows how pharmaceutical companies have been virtually ringfenced out of using social media to promote drugs. (…)

It seems trivial because it is. But tweets, status updates, Facebook “Likes” and other forums in which a drug company’s “official” social media pages can include thousands of added, unapproved comments from members of the public, are proving a huge headache for the highly regulated, risk-averse and deeply conservative world of Big Pharma. (…)

The entire industry awaits policy guidance on social media from the FDA, whose “review” of new digital communications is now in its third calendar year with no final report in sight.

Edwards, Jim. Placebo effect: Bayer apologizes for tweeting: pharma’s never-ending social media nightmare. Online, 6th of July, 2011.




Written by hbasset

July 8, 2011 at 5:03 pm

Pharma goes online: 50 apps from top Big Pharmas

leave a comment »

The popularity of smartphones like the iPhone has created an entirely new marketplace for mobile applications.

Pharmaceutical companies are starting to see the value these apps can provide. A properly designed app-be it a medication tracker, a disease calculator, an educational catalogue, or a patient diary-can improve the lives of patients and physicians and thus increase customer collaboration.

At the same time, a well-designed app in the hands of sales reps and marketers can maximize organizational efficiency and create competitive advantage when it comes to selling drugs.

In the past year, pharma investments in smartphone apps, social media platforms, and wireless devices have grown 78 percent

If you go to the Apple App Store today, you’ll find thousands of medical applications; about 50 of these belong to the pharmaceutical industry. Abbott, AstraZeneca, Bayer, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, and Sanofi-aventis all have apps on the market.

Many of these apps target physicians and nurses:

  • Novartis’ GIST Calculator (Risk of recurrence for Gastrointestinal Stromal Tumors)
  • Roche’s Nursing ACE (educational information for nurses)
  • Johnson & Johnson’s Psoriasis App (calculation of PASI)

or to make the lives of patients better:

  • Merck’s iChemoDiary (record of treatments and medications)
  • Bayer’s Kid-K (gaming for kids with hemophilia)
  • Sanofi-aventis’ GoMeals (nutrition for diabetic population)

When done right, these apps can build a positive association between a brand and a lifestyle and can be integrated into every part of patients’ lives.

Pharma Goes Mobile: Making The Most Of The App Opportunity. Medical News Today, Online, on 24th of March 2011.

Written by hbasset

March 30, 2011 at 7:09 pm